Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival
Australasian Medical Research, Port Vila, Republic of Vanuatu
1 Australasian Medical Research, Port Vila, Republic of Vanuatu
Plant-derived BEC with its main component solamargine possesses anticancer activities via its effect on a variety of biological pathways in a wide range of human cancer cells. High cure rates with BEC therapy have been obtained in animals with deadly cancers, and, in humans with terminal cancers promising results have been reported. At a clinical level, optimal concentrations of BEC have been established in a topical cream formulation Curaderm, for effective removal of skin cancers, but optimal concentrations of BEC have not been reported for other cancers. The objective of this study was to determine whether combination therapy of Cisplatin with BEC would result in synergism using cure rates as end points. BEC on its own cures Sarcoma 180 in mice, whereas, Cisplatin on its own has no effect on Sarcoma 180 activity. A combination of BEC and Cisplatin shows synergism, resulting in higher cure rates than BEC and Cisplatin at comparable individual concentrations.
Davies, C., Gurpinar, E., Paplavska, E., Pinto, A. and Aggarwal, A. (2007) Availability of Evidence of Benefits in Overall Survival and Quality of Life of Cancer Drugs Approved by European Medicines Agency: Retrospective Cohort Study of Drug Approvals 2009-13. BMJ, 359, j4530. https://doi.org/10.1136/bmj.j4530
Cham, B.E., Gilliver, M. and Wilson, L. (1987) Antitumour Effects of Glycoalkaloids Isolated from Solanum sodomaeum. Planta Medica, 53, 34-36. https://doi.org/10.1055/s-2006-962612
Cham, B.E. and Wilson, L. (1987) HPLC of Glycoalkaloids from Solanum sodomaeum. Planta Medica, 53, 59-62. https://doi.org/10.1055/s-2006-962621
Cham, B.E. (1988) Monograph on the Compound BEC. Drugs of the Future, 13, 714-716. https://doi.org/10.1358/dof.1988.013.08.63026
Cham, B.E. and Daunter, B. (1990) Topical Treatment of Premalignant and Malignant Skin Cancers with Curaderm. Drugs of Today, 26, 55-58.
Daunter, B. and Cham, B.E. (1990) Solasodine Glycosides. In Vitro Preferential Cytotoxicity for Human Cancer Cells. Cancer Letters, 55, 209-220. https://doi.org/10.1016/0304-3835(90)90121-D
Cham, B.E. and Daunter, B. (1990) Solasodine Glycosides. Selective Cytotoxicity for Cancer Cells and Inhibition of Cytotoxicity by Rhamnose in Mice with Sarcoma 180. Cancer Letters, 55, 221-225. https://doi.org/10.1016/0304-3835(90)90122-E
Cham, B.E. (2017) Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies. International Journal of Clinical Medicine, 8, 692-713. https://doi.org/10.4236/ijcm.2017.812064
Cham, A., Cham, K., Chase, T. and Cham, B. (2015) A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5. Journal of Cancer Treatment and Research, 3, 22-27. https://doi.org/10.11648/j.jctr.20150302.12
Lipscombe, R., Carter, S. and Ruane, M. (2005) Rhamnose Binding Protein. USA Patent No. 6930171.
Cham, B.E. (2000) Medicinal Compositions and Their Method of Preparation. 2000 Patent No. WO 00/61153.
Cham, B.E. (2007) Solasodine Rhamnosyl Glycosides Specifically Bind Cancer Cell Receptors and Induce Apoptosis and Necrosis. Treatment for Skin Cancer and Hope for Internal Cancers. Research Journal of Biological Sciences, 2, 503-514.
Wang, Y.Y., Gao. J., Gu, G.F., Li, G., Cui, C.Z., Sun, B. and Lou, H.X. (2011) In Situ RBL Receptor Visualisation and Its Mediated Anticancer Activity for Solasodine Rhamnosides. ChemBioChem, 12, 2418-2420. https://doi.org/10.1002/cbic.201100551
Cham, B.E. (1994) Solasodine Glycosides as Anticancer Agents: Preclinical and Clinical Studies. Asia Pacific Journal of Pharmacology, 9, 113-118.
An, W.X., Lai, H.L., Zhang, Y.Y., Liu, M.H., Lin, X.K. and Cao, S.S. (2019) Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines. Frontiers in Pharmacology, 10, Article 758. https://doi.org/10.3389/fphar.2019.00758
Li, X., Zhao, Y., Wu, W.K.K., Liu, S.S., Cui, M. and Lou, H.X. (2011) Solamargine Induces Apoptosis with p53 Transcription-Dependent and Transcription-Independent Pathways in Human Osteosarcoma U2OS Cells. Life Science, 88, 314-321. https://doi.org/10.1016/j.lfs.2010.12.006
Al Sinani, S.S., Eltayeb, E.A., Coomber, B.L. and Adham, S.A. (2016) Solamargine Triggers Cellular Necrosis Selectively in Different Types of Human Melanoma Cancer Cells Through Extrinsic Lysosomal Mitochondrial Death Pathways. Cancer Cell International, 16, Article No. 11. https://doi.org/10.1186/s12935-016-0287-4
Zang, X.H., Yan, Z.P., Xu, T.T., An, Z.T., Chen, W.Z., Wang, X.S., Huang, M.M. and Zhu, F.S. (2018) Solamargine Derived from Solanum Nigrum Induces Apoptosis of Human Cholangiocarcinoma QBC939 Cells. Oncology Letters, 15, 6329-6335. https://doi.org/10.3892/ol.2018.8171
Al Sinani, S.S.S. and Eltayeb, E.A. (2017) The Steroidal Glycoalkaloids Solamargine and Solasonine in Solanum Plants. South African Journal of Botany, 112, 253-269. https://doi.org/10.1016/j.sajb.2017.06.002
Kalalinia, F. and Korimi-Sani, I. (2017) Anticancer Properties of Solamargine: A Systematic Review. Phytotherapy Research, 31, 858-870. https://doi.org/10.1002/ptr.5809
Fu, R.J., Wang, X.H., Hu, Y., Du, H., Deng, B., Ao, S., Zhang, L., Sun, Z., Zhang, L.H., Lv, G.Q. and Ji, J.F. (2019) Solamargine Inhibits Gastric Cancer Progression by Regulating the Expression of lncNEAT1_2 via the MAPK Signaling Pathway. International Journal of Oncology, 54, 1545-1554. https://doi.org/10.3892/ijo.2019.4744
Sani, I.K., Marashi, S.H. and Kalalinia, F. (2015) Solamargine Inhibits Migration and Invasion of Human Hepatocellular Carcinoma Cells through Down-Regulation of Matrix Metalloproteinases 2 and 9 Expression and Activity. Toxicology in Vitro, 29, 893-900. https://doi.org/10.1016/j.tiv.2015.03.012
Li, X., Zhao, Y., Liu, S., Cui, M. and Lou, H. (2011) Induction of Actin Disruption and Downregulation of P-Glycoprotein Expression of Solamargine in Multidrug-Resistant K562/A02 Cells. Chinese Medical Journal, 124, 2038-2044.
Cham, B.E. (2013) Drug Therapy: Solamargine and Other Solasodine Rhamnosyl Glycosides as Anticancer Agents. Modern Chemotherapy, 2, 33-49. https://doi.org/10.4236/mc.2013.22005
Cham, B.E. (2013) Inspired by Nature, Proven by Science. The New Generation Cancer Treatment That Causes Cancer Cells to Commit Suicide. Colorite Graphics, Republic of Vanuatu, 264 p.
Cham, B.E. (2007) Solasodine Rhamnosyl Glycosides Specifically Bind Cancer Cell Receptors and Induce Apoptosis and Necrosis. Treatment for Skin Cancer and Hope for Internal Cancers. Research Journal of Biological Sciences, 2, 503-514.
Cham, B.E. and Daunter, B. (1990) Solasodine Glycosides. Selective Cytotoxicity for Cancer Cells and Inhibition of Cytotoxicity by Rhamnose in Mice with Sarcoma 180. Cancer Letters, 55, 221-225. https://doi.org/10.1016/0304-3835(90)90122-E
Wu, Y.H., Chiu, W.T., Young, M.J., Chang, T.H., Huang, Y.F. and Chou, C.Y. (2015) Solanum incanum Extract down Regulates Aldehyde Dehydrogenase 1-Medicated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells. Journal of Cancer, 6, 1011-1019. https://doi.org/10.7150/jca.12738
Cham, B.E. (2013) Drug Therapy: Solamargine and Other Solasodine Rhamnosyl Glycosides as Anticancer Agents. Modern Chemotherapy, 2, 33-49. https://doi.org/10.4236/mc.2013.22005
Yu, S., Sheu, H.M. and Lee, C.H. (2017) Solanum incanum Extract (SR-T100) Induces Melanoma Cell Apoptosis and Inhibits Established Lung Metastasis. Oncotarget, 8, 103509-103517.
Wu, J., Tang, X., Ma, C., Shi, Y., Wu, W. and Hann, S. (2020) The Regulation and Interaction of Colon Cancer-Associated Transcript-1 and MiR7-5p Contribute to the Inhibition of SP1 Expression by Solamargine in Human Nasopharyngeal Carcinoma Cells. Phytotherapy Research, 34, 201-213. https://doi.org/10.1002/ptr.6555
Pee, H.N. (2016) Evaluation of Solamargine as a Therapeutic in Bladder Cancer. Scholar Bank@NUS Repository.
Cham, B.E. (2008) Cancer Intralesion Chemotherapy with Solasodine Rhamnosyl Glycosides. Research Journal of Biological Sciences, 3, 1008-1017.
Shiu, L.Y., Chang, L.C., Liang, C.H., Huang, Y.S., Sheu, H.M. and Kuo, K.W. (2007) Solamargine Induces Apoptosis and Sensitizes Breast Cancer Cells to Cisplatin. Food and Chemical Toxicology, 45, 2155-2164. https://doi.org/10.1016/j.fct.2007.05.009
Sun, L.M., Zhao, Y., Li, X., Yuan, H.Q., Cheng, A. and Lou, H.X. (2010) A Lysosomal-Mitochondrial Death Pathway Is Induced by Solamargine in Human K562 Leukemia Cells. Toxicology in Vitro, 24, 1504-1511. https://doi.org/10.1016/j.tiv.2010.07.013
Xiang, S.T., Zhang, Q.H., Tang, Q., Zheng, F., Wu, J.J., Yang, L.J. and Hann, S.S. (2016) Activation of AMPKα Mediates Additive Effects of Solamargine and Metformin on Suppressing MUC1 Expression in Castration-Resistant Prostate Cancer Cells. Scientific Reports, 6, Article No. 36721. https://doi.org/10.1038/srep36721
Kuo, K.W., Hsu, S.H., Li, Y.P., Lin, W.L., Liu, L.F., Chang, L.C., Lin, C.N., Lin, C.C. and Sheu, H.M. (2000) Anticancer Activity Evaluation of the Solanum Glycoalkaloid Solamargine. Triggering Apoptosis in Human Hepatoma Cells. Biochemical Pharmacology, 60, 865-1873. https://doi.org/10.1016/S0006-2952(00)00506-2
Liang, C.H., Liu, L.F., Shiu, L.Y., Huang, Y.S., Chang, L.C. and Kuo, K.W. (2004) Action of Solamargine on TNFs and Cisplatin-Resistant Human Lung Cancer Cells. Biochemical and Biophysical Research Communications, 322, 751-758. https://doi.org/10.1016/j.bbrc.2004.07.183
Xie, X.D., Zhang, X.M., Chen, J., Tang, X., Wang, M.Q., Zhang, L., Guo, Z. and Shen, W.R. (2019) Fe3O4-Solamargine Induces Apoptosis and Inhibits Metastasis of Pancreatic Cancer Cells. International Journal of Oncology, 54, 905-915. https://doi.org/10.3892/ijo.2018.4637
Millward, M., Powell, A., Tyson, S., Daly, P., Ferguson, R., and Carter, S. (2005) Phase 1 Trial of Coramsine (SBP002) in Patients with Advanced Solid Tumors. Journal of Clinical Oncology, 23, 3105. https://doi.org/10.1200/jco.2005.23.16_suppl.3105
Munari, C.C., De Oliveira, P.F., Campos, J.C.L., Martins, S.P.L., Da Costa, J.C., Bastos, J.K. and Tavares, D.C. (2014) Antiproliferative Activity of Solanum lycocarpum Alkaloidal Extract and Their Constituents, Solamargine and Solasonine, in Tumor Cell Lines. Journal of Natural Medicines, 68, 236-241. https://doi.org/10.1007/s11418-013-0757-0
Cham, B.E. and Meares, H.M. (1987) Glycoalkaloids from Solanum sodomaeum are Effective in the Treatment of Skin Cancers in Man. Cancer Letters, 36, 111-118. https://doi.org/10.1016/0304-3835(87)90081-4
Cham, B.E., Daunter, B. and Evans, R. (1991) Topical Treatment of Malignant and Premalignant Skin Cancers by Very Low Concentrations of a Standard Mixture (BEC) of Solasodine Glycosides. Cancer Letters, 59, 183-192. https://doi.org/10.1016/0304-3835(91)90140-D
Punjabi, S., Cook, I., Kersey, P., Marks, R., Finlay, A., Sharpe, G. and Cerio, R. (2000) A Double Blind, Multi-Centre Parallel Group Study of BEC-5 Cream in Basal Cell Carcinoma. Journal of the European Academy of Dermatology and Venereology, 14, 47-60.
Tambuscio, A., Siliprandi, L., Dario, M., Cham, A., Cham, B. and Bordignon, M. (2016) Treatment of Cutaneous Carcinomas with a Topical Cream Containing Solasodine Rhamnosides: Focus on Efficacy, Compliance and Cosmetic Outcomes. European Academy of Dermatology and Venereology, Athens, Greece.
Cham, B.E. (2007) The Eggplant Cancer Cure: A Treatment for Skin Cancers and New Hope for Other Cancers from Nature’s Pharmacy. Smart Publications, Petaluma, California, USA.
Cham, B.E. (2007) Solasodine Rhamnosyl Glycosides in a Cream Formulationis Effective for Treating Large and Troublesome Skin Cancers. Research Journal of Biological Sciences, 2, 749-761.
Cham, B.E. (2009) When Does Alternative Become Orthodox? Skin Cancer Treatment with Solasodine Rhamnosyl Glycosides in Its Transitional Stage, a Case Study. Evidence-Based Complementary and Alternative Medicine, 6, 415-420.
Cham, B.E. (2011) Topical Solasodine Rhamnosyl Glycosides Derived from the Eggplant Treats Large Skin Cancers: Two Case Reports. International Journal of Clinical Medicine, 2, 473-477. https://doi.org/10.4236/ijcm.2011.24080
Chase, T.R. (2011) CuradermBEC5 for Skin Cancers, Is It? An Overview. Journal of Cancer Therapy, 2, 728-745. https://doi.org/10.4236/jct.2011.25099
Cham, B.E. (2012) Intralesion and CuradermBEC5 Topical Combination therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared. International Journal of Clinical Medicine, 3, 115-124. https://doi.org/10.4236/ijcm.2012.32024
Cham, B.E. (2013) Topical CuradermBEC5 Therapy for Periocular Nonmelanoma Skin Cancer: A Review of Clinical Outcomes. International Journal of Clinical Medicine, 4, 233-238. https://doi.org/10.4236/ijcm.2013.45041
Cham, B.E. (2013) Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5. Journal of Cancer Therapy, 4, 588-596. https://doi.org/10.4236/jct.2013.42076
Cham, B.E. (2014) A Review of Solasodine Rhamnosides Therapy for In-Situ Squamous Cell Carcinoma on the Penis. British Journal of Medicine and Medical Research, 4, 621-631. https://doi.org/10.9734/BJMMR/2014/4677
Cham, A. and Cham, B.E. (2015) Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides. International Journal of Clinical Medicine, 6, 326-333. https://doi.org/10.4236/ijcm.2015.65042
Cham, B.E., Cham, K., Cham, A., Chase, T. and Zhou, V. (2015) Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities. Journal of Cancer Therapy, 6, 1045-1053. https://doi.org/10.4236/jct.2015.612114
Batsev, A.F., Dobrokhotova, V.Z. and Cham, B.E. (2016) Topical Cream Curadermbec5 Treats a Recalcitrant Basal Cell Carcinoma. Clinical Medicine Review and Case Reports, 3, 098. https://doi.org/10.23937/2378-3656/1410098
Goldberg, L.H., Landau, J.M., Moody, M.N. and Vergilis-Kalner, I.J. (2011) Treatment of Bowen’s Disease on the Penis with Low Concentrations of a Standard Mixture of Solasodine Glycosides and Liquid Nitrogen. Dermatologic Surgery, 37, 858-861. https://doi.org/10.1111/j.1524-4725.2011.02014.x
Punjabi, S., Cook, L.J., Kersey, P., Marks, R. and Cerio, R. (2008) Solasodine Glycoalkaloids: A Novel Topical Therapy for Basal Cell Carcinoma. A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicentre Study. International Journal of Dermatology, 47, 78-82. https://doi.org/10.1111/j.1365-4632.2007.03363.x
Bordingnon, M. (2016) Efficacy and Safety of CuradermBEC5 in the Treatment of Basal Cell Carcinoma: A Pilot Study in the Italian Population. European Academy of Dermatology and Venereology Congress, Athens, Greece.
Dobrokhotova, F.Z., Betsev, A.F. and Belysheva, T.S. (2016) The Use of Kuraderm Drug in the Treatment of Basal Cell Carcinoma of the Head and Neck. Head and Neck Tumors, 6, 22-26.
Van Der Most, R.G., Himbeck, R., Aarons, S., Carter, S.J., Larma, I., Robinson, C., Currie, A. and Lake, R.A. (2006) Antitumor Efficacy of the Novel Chemotherapeutic Agent Coramsine Is Potentiated by Cotreatment with CpG-Containing Oligodeoxynucleotides. The Journal of Immunology, 29, 134-142. https://doi.org/10.1097/01.cji.0000187958.38179.a9
Solbec Pharmaceut (2005) Pre-IND Submission 5.
Zeng, X., Xu, L., Liang, Y., Xiao, W., Xie, L., Zhang, Y., Zhao, L., Cao, L., Chen, J. and Wang, G. (2011) Quantitative Determination and Pharmacokinetic Study of Solamargine in Rat Plasma by Liquid Chromatography-Mass Spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 55, 1157-1162. https://doi.org/10.1016/j.jpba.2011.04.007
Millward, M., Powell, A., Daly, P., Tyson, S., Ferguson, R. and Carter, S. (2006) Results of Phase I Clinical Trials of Coramsine in Patients with Advanced Solid Tumors. Journal of Clinical Oncology, 24, 2070. https://doi.org/10.1200/jco.2006.24.18_suppl.2070
Cham, B.E., Chase, T.R. and Cham, K.E. (2020) Glycoalkaloid Combinations and Various Uses Thereof. Patent PCT/AU2017/050188.
Hall, M., Telma, K., Chang, K., Lee, T., Madigan, J., Lloyd, J., Goldlust, I., Hoeschele, J. and Gottesman, H. (2014) Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes. Cancer Research, 74, 3913-3922. https://doi.org/10.1158/0008-5472.CAN-14-0247